TTS Pharma Ltd

News

For media enquiries, please contact our press office : ttspharma@sciad.com

Press and Media

CBD Product Approval Awareness Event. Webinar by UKAS & FSA, August 2020.

Winning in CBD: Learn how to innovate in the CBD space effectively whilst being legally compliant. Webinar by MMR Research, 04th of August 2020 – Cubo Winning In CBD

Top 10 European Cannabis Tech Startups to Watch Out in 2020 – IndustryWired, July 2020

CBD and transparency: Not all CBDs are the same – Cosmetics Business, June 2020

Can you afford to ignore the CBD Market? – P3 Pharmacy, March 2020

CBD Trending ingredient or ingredient trend? – Food Navigator.com, January 2020

The Global Cannabinoid Pharmaceutical Industry – European Pharmaceutical Review, December 2019

What does legal limbo mean for CBD – Food Navigator.com, December 2019

TTS Pharma tests reveal labelling issues amongst CBD products – Nutraingredients.com, October 2019

CBD the science behind purity – European Pharmaceutical Review (EPR), September 2019

An “unrestrained” market? Survey highlights “illegal and unsafe” CBD products on UK market – Nutrition Insight, September 2019

Analysis shows THC and contaminants rife in UK CBD products – The Leaf Desk, September 2019

Research Commercial cannabidiol on the UK market is illegal -Cleanroom Technology, September 2019

Research Commercial cannabidiol on the UK market is illegal  – Manufacturing Chemist, September 2019

Research Commercial cannabidiol on the UK market is illegal – Nutraceutical Business Review, September 2019

Patience Wins The Race – Pharma Intelligence, September 2019

Actuality

CBD Products – Safety Data & Novel Foods Application

TTS Pharma have formed the first Primary Authority (PA) partnership in the United Kingdom for CBD products.

TTS Pharma is the first UK manufacturer to produce commercial cannabidiol free of illegal THC and CBN

TTS Pharma Limited – Announces closing of £10.3 million fundraising and new board appointment